The Diagnostic Ability of Procalcitonin to Differentiate Gram-negative Bacteria from Gram-positive Bacteria and Fungal Bloodstream Infections in Critically Ill Patients

Di Wang,Xiaogen Tao,Wei Guo,Haihua Liu,Shu Cheng,Jinquan Wang
DOI: https://doi.org/10.1177/2058739219841469
2019-01-01
European Journal of Inflammation
Abstract:Bloodstream infection (BSI) is a severe infectious complication in critically ill patients. This study was aimed to investigate the diagnostic accuracy of procalcitonin (PCT) to differentiate Gram-negative bacteria (Gram-neg) from Gram-positive bacteria (Gram-pos) and fungal BSI. PCT and other inflammation markers of monomicrobial BSI patients were retrospectively collected and compared between patients with Gram-neg, Gram-pos, or fungal BSI. The differential diagnosis performance of PCT was evaluated by receiver operating characteristic curves (ROC). The area under curve (AUC) of PCT for differentiating Gram-neg BSI from Gram-pos BSI was 0.95 with an optimal cut-off value of 4.15 ng/mL, a sensitivity of 82.05%, and a specificity of 96.15%. AUC of PCT for differentiating Gram-neg BSI from fungal BSI was 0.92 with an optimal cut-off value of 3.13 ng/mL, a sensitivity of 84.62%, and a specificity of 88.89%. Serum PCT concentration can be used to differentiate Gram-neg from Gram-pos and fungal BSI.
What problem does this paper attempt to address?